Mental health and wellness company focused on investigation of psychoactive, psychedelic, and nootropic compounds, Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) has filed for provisional patent with the United States Patent and Trademark Office (USPTO) for its proprietary digital therapeutics tool iSTRYM.
The company views this as a milestone accomplished because the initiative targets both the therapists and patients it also uses data and feedback from patients improve on diagnosis and treatment.
The company’s founder and chief executive officer Kelsey Ramsden believes this is a milestone and a breakthrough in psychedelics experiences with a science background.
“We intend to build iSTRYM into the world’s largest data repository of psychedelic experiences, backed by science and built on trust,” added the CEO.
